Cranial Osteopathy in Functional Disorders of the Newborn

NCT ID: NCT03751787

Last Updated: 2018-11-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-09-30

Study Completion Date

2016-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate, from the maternity stay, the interest of the cranial osteopathy in the reduction of the hyper irritability of the newborn and the improvement of the postural abnormalities

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Newborn Complication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

cranial osteopathy

The group will receive treatment with osteopathic cranial osteopathy

Group Type EXPERIMENTAL

cranial osteopathy

Intervention Type OTHER

two sessions at three weeks intervals

comfort massage

The group will benefit from a placebo manipulation by an osteopathic student who has not yet been trained in cranial osteopathy.

Group Type PLACEBO_COMPARATOR

comfort massage

Intervention Type OTHER

manipulation, comfort massage, standardized and not affecting the skull

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cranial osteopathy

two sessions at three weeks intervals

Intervention Type OTHER

comfort massage

manipulation, comfort massage, standardized and not affecting the skull

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Newborns:

* forward
* born vaginally or cesarean section
* with or without general anesthesia
* with or without epidural or spinal anesthesia
* with or without instrumental extraction
* presenting at least 1 of the 4 criteria detailed above, numbered at 3 or 4 or two criteria at 2

Exclusion Criteria

* Newborns presenting:

* a score of Amiel \<7, signing a strong suspicion of non-integrity of brain functions (see table) and therefore leaving the framework of functional pathology
* symptomatic maternal-fetal infection
* true obstetric trauma: brachial plexus paralysis, fracture
* or of a mother who has taken during pregnancy drugs or toxic drugs that affect the behavior of the newborn. (benzodiazepines, subutex, methadone, cocaine, heroin or cannabis)
Minimum Eligible Age

1 Minute

Maximum Eligible Age

29 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Lille

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eric Boez, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Lille

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maternité Paul Gelé du CH de Roubaix

Roubaix, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2009-A00037-50

Identifier Type: OTHER

Identifier Source: secondary_id

2008_43

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.